Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 7,490,605,600
  • Shares Outstanding, K 51,450
  • 60-Month Beta 0.84
Trade IBB with:
  • Price/Earnings ttm 15.68
  • Annual Dividend & Yield 0.45 (0.31%)
  • Most Recent Dividend 0.200 on 09/25/24
  • Management Fee 0.44%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 18.96% ( -1.87%)
  • Historical Volatility 15.17%
  • IV Percentile 63%
  • IV Rank 22.75%
  • IV High 33.78% on 08/05/24
  • IV Low 14.59% on 07/10/24
  • Put/Call Vol Ratio 0.66
  • Today's Volume 3,255
  • Volume Avg (30-Day) 3,597
  • Put/Call OI Ratio 2.07
  • Today's Open Interest 152,847
  • Open Int (30-Day) 176,366

Price Performance

See More
Period Period Low Period High Performance
1-Month
141.70 +2.75%
on 10/07/24
150.57 -3.30%
on 09/19/24
-0.03 (-0.02%)
since 09/11/24
3-Month
137.69 +5.74%
on 08/05/24
150.57 -3.30%
on 09/19/24
+1.74 (+1.21%)
since 07/11/24
52-Week
111.83 +30.19%
on 10/31/23
150.57 -3.30%
on 09/19/24
+21.96 (+17.76%)
since 10/11/23

Most Recent Stories

More News
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now

The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.

IBB : 145.59 (+1.70%)
GILD : 84.95 (+0.33%)
XBI : 98.68 (+2.56%)
Why Biotech ETFs Are Beating the Market

Biotech stocks have been outperforming the broader market over the past three months, driven by optimism regarding potential rate cuts. The Fed is expected to start cutting rates later this month, and...

REGN : 1,015.67 (+1.67%)
GILD : 84.95 (+0.33%)
IBB : 145.59 (+1.70%)
XBI : 98.68 (+2.56%)
SBIO : 38.32 (+3.64%)
Regeneron Pharmaceuticals Stock Outlook: Is Wall Street Bullish or Bearish?

Regeneron Pharmaceuticals has outperformed the broader market over the past year, and Wall Street analysts remain bullish on the stock’s prospects.

REGN : 1,015.67 (+1.67%)
$SPX : 5,815.03 (+0.61%)
$SPX : 5,815.03 (+0.61%)
IBB : 145.59 (+1.70%)
IBB : 145.59 (+1.70%)
3 ETFs for Growth Investors to Buy and Hold for Decades

These exchange-traded funds can help you easily tap into some promising growth opportunities.

IVZ : 17.69 (+0.06%)
AAPL : 227.55 (-0.65%)
NVDA : 134.80 (-0.01%)
QQQ : 493.36 (+0.16%)
IBB : 145.59 (+1.70%)
IWF : 380.01 (+0.20%)
Gilead Sciences' Q2 2024 Earnings: What to Expect

Gilead Sciences is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit profit increase.

GILD : 84.95 (+0.33%)
$SPX : 5,815.03 (+0.61%)
IBB : 145.59 (+1.70%)
Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy

You don't need to be a stock market expert to earn above-average returns.

VGT : 600.44 (+0.31%)
VOO : 532.71 (+0.59%)
IXJ : 97.74 (+0.63%)
IYH : 64.88 (+0.87%)
IBB : 145.59 (+1.70%)
IHI : 58.61 (+0.43%)
How Is Regeneron Pharmaceuticals' Stock Performance Compared to Other Biotechnology Stocks?

Regeneron Pharmaceuticals has outperformed the broader market over the past year, and Wall Street analysts are optimistic about the stock’s outlook.

REGN : 1,015.67 (+1.67%)
IBB : 145.59 (+1.70%)
AMGN : 328.35 (+2.29%)
You Don't Have to Pick a Winner in Biotech. Here's Why.

If you invest over the long term, you'll increase your chances of victory.

IBB : 145.59 (+1.70%)
This Biotech Stock Offers Innovative Growth at a Massive Discount

Moderna stock continues to sag, even as new COVID variants emerge. However, investors may be underestimating the potential of the mRNA pipeline.

IBB : 145.59 (+1.70%)
MRNA : 58.29 (+2.57%)
3 Strong Biotech Performers To Watch As Sector Nears Breakout

As the IBB ETF nears a potential breakout, watch for strong performers like Regeneron Pharmaceuticals, Vertex, and Exelixis to continue outperforming.

EXEL : 26.23 (+2.02%)
IBB : 145.59 (+1.70%)
REGN : 1,015.67 (+1.67%)
VRTX : 481.71 (+1.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

3rd Resistance Point 149.45
2nd Resistance Point 147.56
1st Resistance Point 146.57
Last Price 145.59
1st Support Level 143.69
2nd Support Level 141.80
3rd Support Level 140.81

See More

52-Week High 150.57
Last Price 145.59
Fibonacci 61.8% 135.77
Fibonacci 50% 131.20
Fibonacci 38.2% 126.63
52-Week Low 111.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar